The tumor suppressor roles of miR-433 and miR-127 in gastric cancer

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14171-14184

  Guo, Li Hua ^a   Li, Hui ^b   Wang, Fang ^c   Yu, Jia ^c   He, Jin Sheng ^a  

^a BEIJING JIAOTONG UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Gastric cancer; KRAS; MAPK4; miR 127; miR 433

Indexed keywords

K RAS PROTEIN; MICRORNA; MICRORNA 217; MICRORNA 433; MITOGEN ACTIVATED PROTEIN KINASE 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STAGING; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAPK4 GENE; ONCOGENE K RAS; PROTEIN DEPLETION; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GENE;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; HYDROXAMIC ACIDS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; RAS PROTEINS; STOMACH NEOPLASMS;

EID: 84880167281     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714171     Document Type: Article

References (29)

1. Ezzati, M.; Henley, S.J.; Lopez, A.D.; Thun, M.J. Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. Int. J. Cancer. 2005, 116, 963-971.
2. Calin, G.A.; Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857-866.
3. Kong, Y.W.; Ferland-McCollough, D.; Jackson, T.J.; Bushell, M. MicroRNAs in cancer management. Lancet Oncol. 2012, 13, e249-e258.
4. Gao, W.; He, H.W.; Wang, Z.M.; Zhao, H.; Lian, X.Q.; Wang, Y.S.; Zhu, J.; Yan, J.J.; Zhang, D.G.; Yang, Z.J., et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis. 2012, 11, doi:10.1186/1476-511X-11-55.
5. Fernandez-Hernando, C.; Moore, K.J. MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2378-2382.
6. El Abiad, R.; Gerke, H. Gastric cancer: Endoscopic diagnosis and staging. Surg. Oncol. Clin. N. Am. 2012, 21, 1-19.
7. Rayner, K.J.; Esau, C.C.; Hussain, F.N.; McDaniel, A.L.; Marshall, S.M.; van Gils, J.M.; Ray, T.D.; Sheedy, F.J.; Goedeke, L.; Liu, X., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478, 404-407.
8. Song, G.; Wang, L. A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One 2009, 4, e7829.
9. Yang, Z.; Zhang, Y.; Wang, L. A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13. PLoS One 2013, 8, e65256.
10. Luo, H.; Zhang, H.; Zhang, Z.; Zhang, X.; Ning, B.; Guo, J.; Nie, N.; Liu, B.; Wu, X. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res. 2009, 28, doi:10.1186/1756-9966-28-82.
11. Ueda, T.; Volinia, S.; Okumura, H.; Shimizu, M.; Taccioli, C.; Rossi, S.; Alder, H.; Liu, C.G.; Oue, N.; Yasui, W., et al. Relation between microRNA expression and progression and prognosis of gastric cancer: A microRNA expression analysis. Lancet Oncol. 2010, 11, 136-146.
12. Lin, X.; Rice, K.L.; Buzzai, M.; Hexner, E.; Costa, F.F.; Kilpivaara, O.; Mullally, A.; Soares, M.B.; Ebert, B.L.; Levine, R., et al. MiR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia 2013, 27, 344-352.
13. Tsai, K.W.; Wu, C.W.; Hu, L.Y.; Li, S.C.; Liao, Y.L.; Lai, C.H.; Kao, H.W.; Fang, W.L.; Huang, K.H.; Chan, W.C., et al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int. J. Cancer 2011, 129, 2600-2610.
14. Lukaszewicz-Zajac, M.; Mroczko, B.; Szmitkowski, M. Gastric cancer-The role of matrix metalloproteinases in tumor progression. Clin. Chim. Acta 2011, 412, 1725-1730.
15. Gurzu, S.; Szentirmay, Z.; Bara, T.; Turcu, M.; Toth, E.; Bara, T., Jr.; Jung, I. Non-Epstein-Barr virus associated lymphoepithelioma-like carcinoma of the esophagogastric junction with microsatellite instability, K-ras wild type. Pathol. Res. Pract. 2013, 209, 128-131.
16. Parikh, N.; Shuck, R.L.; Nguyen, T.A.; Herron, A.; Donehower, L.A. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses. Mol. Cancer Res. 2012, 10, 845-855.
17. Betge, J.; Pollheimer, M.J.; Schlemmer, A.; Hoefler, G.; Langner, C. Gastric cancer and concomitant renal cancer: A systematic immunohistochemical and molecular analysis. Oncol. Rep. 2011, 26, 567-575.
18. Nana-Sinkam, S.P.; Croce, C.M. Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 2013, 93, 98-104.
19. Leonardo, T.R.; Schultheisz, H.L.; Loring, J.F.; Laurent, L.C. The functions of microRNAs in pluripotency and reprogramming. Nat. Cell Biol. 2012, 14, 1114-1121.
20. Van Rooij, E.; Olson, E.N. MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat. Rev. Drug Discov. 2012, 11, 860-872.
21. Cimmino, A.; Calin, G.A.; Fabbri, M.; Iorio, M.V.; Ferracin, M.; Shimizu, M.; Wojcik, S.E.; Aqeilan, R.I.; Zupo, S.; Dono, M., et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 2005, 102, 13944-13949.
22. Kang, H.W.; Crawford, M.; Fabbri, M.; Nuovo, G.; Garofalo, M.; Nana-Sinkam, S.P.; Friedman, A. A mathematical model for microRNA in lung cancer. PLoS One 2013, 8, e53663.
23. Fowler, A.; Thomson, D.; Giles, K.; Maleki, S.; Mreich, E.; Wheeler, H.; Leedman, P.; Biggs, M.; Cook, R.; Little, N., et al. MiR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur. J. Cancer 2011, 47, 953-963.
24. Matsubara, A.; Sekine, S.; Kushima, R.; Ogawa, R.; Taniguchi, H.; Tsuda, H.; Kanai, Y. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J. Pathol. 2013, 229, 579-587.
25. Omar, M.F.; Ito, K.; Nga, M.E.; Soo, R.; Peh, B.K.; Ismail, T.M.; Thakkar, B.; Soong, R.; Ito, Y.; Salto-Tellez, M. RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRASstatus. Pathol. Oncol. Res. 2012, 18, 783-792.
26. Fujimori, Y.; Inokuchi, M.; Takagi, Y.; Kato, K.; Kojima, K.; Sugihara, K. Prognostic value of RKIP and p-ERK in gastric cancer. J. Exp. Clin. Cancer Res. 2012, 31, 30.
27. Park, E.; Park, J.; Han, S.W.; Im, S.A.; Kim, T.Y.; Oh, D.Y.; Bang, Y.J. NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations. Int. J. Oncol. 2012, 40, 1259-1266.
28. Song, G.; Wang, L. Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res. 2008, 36, 5727-5735.
29. Song, G.; Wang, L. MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus. PLoS One 2008, 3, e3574.